Recombinant Human Stem Cell
Factor
Certificate
of Analysis and Data Sheet
×
Description:
Recombinant
Human SCF produced in E.Coli is a single, non-glycosylated polypeptide chain containing 164 amino acids and
having a molecular mass of 18409 Dalton.
The SCF is purified by proprietary
chromatographic techniques.
×
Source:
×
Lot
Number: #
×
Quantity
Shipped:
×
Physical
Appearance:
Sterile
Filtered White lyophilized (freeze-dried) powder.
×
Formulation
& packaging:
Solubility:
The lyophilized rHuSCF is very soluble in water and most aqueous buffers below and above the isoelectric point.
×
Stability:
Lyophilized
rHuSCF although stable at room temperature, should be
stored desiccated below 0°C.
Reconstituted rHuSCF is best stored refrigerated at
4°C.
×
Purity:
Greater
than 98.0% as
determined by:
(a) Analysis by
RP-HPLC.
(b)
Anion-exchange FPLC.
(c) Analysis by reducing and
non-reducing SDS-PAGE Silver Stained.
(Limit
of acceptance:³98.0%.
No more than 2% total impurities; no single impurity greater than
1%)
×
Amino
Acid Composition:
In total agreement with the expected amino acid composition of native human SCF.
×
Amino
acid sequence:
The
sequence of the first five N-terminal amino acids was determined and was found
to be Met-Glu-Gly-Ile-Cys, conforming to the sequence of native human SCF.
×
Dimers
and aggregates:
Less
than 1% as determined by silver-stained SDS-PAGE gel analysis.
×
Biological
Activity:
Our
rHuSCF is fully biologically active when compared to
standard.
The
ED50
as
determined by the dose-dependant stimulation of Human TF-1
cells
is
< 2 ng/ml, corresponding to a Specific Activity of 5x105
IU/mg.
×
Endotoxin:
Less
than 0.1 ng/µg (IEU/µg) of rHuSCF.
×
Protein
content:
Protein quantitation was carried out by
two independent methods:
1. UV spectroscopy at 280 nm.
2. Analysis by RP-HPLC, using a standard
solution of SCF as a Reference Standard.
×
Usage:
This material is offered for research, laboratory or further manufacturing purposes.
Send e-mail to:
customer_service@abazyme.com with questions or comments.
|